Results 101 to 110 of about 92,725 (294)

Continuous Renal Replacement Therapy: Case Vignettes

open access: yes, 2017
The most common indication for continuous renal replacement therapy (CRRT) in critically ill patients is acute kidney injury with hemodynamic instability.
Craig Sadler   +4 more
core   +1 more source

Lyophilized Synthetic Platelets: In Vitro Characterization and in Vivo Evaluation in Mouse Thrombocytopenia Model

open access: yesAdvanced Science, EarlyView.
ABSTRACT Platelet transfusions to treat bleeding complications use donor‐derived platelets stored at room‐temperature, that have a shelf‐life of only 5–7 days due to bacterial contamination risks. Cold‐stored and freeze‐dried platelets are being investigated for extending shelf‐life, but these still have the inherent challenge of donor‐dependency.
Ujjal Didar Singh Sekhon   +20 more
wiley   +1 more source

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN DIABETIC PATIENTS

open access: yesTurkish Journal of Nephrology, 2019
ccording to recent reports, the most common cause of chronic renal failure (CRF) is diabetic nephropathy. United States Renal Data System (USRDS) showed that in 1989, 3 % of all new CRF patients accepted for renal replacement therapy (RRT) were diabetic.
Taner ÇAMSAR, Caner ÇAVDAR
doaj  

Development of a vancomycin dosing approach for critically ill patients receiving hybrid hemodialysis using Monte Carlo simulation

open access: yesSAGE Open Medicine, 2018
Objectives: Prolonged intermittent renal replacement therapy is an increasingly popular treatment for acute kidney injury in critically ill patients that runs at different flow rates and durations than conventional hemodialysis or continuous renal ...
Susan J Lewis, Bruce A Mueller
doaj   +1 more source

A Biomimetic Lubricant Captures Hyaluronic Acid In Situ to Regenerate Cartilage: From Bench to Bedside

open access: yesAdvanced Science, EarlyView.
(a) The outstanding lubricative properties of natural articular cartilage arise from a composite coating composed of HA, lubricin, and phospholipids at its surface. Notably, lubricin facilitates the enrichment of synovial HA onto cartilage surfaces, and HA complexes with phospholipids, a key component to maintain extremely low friction under high ...
Yongan Lin   +12 more
wiley   +1 more source

How I prescribe continuous renal replacement therapy

open access: yesCritical Care, 2021
Emily J. See, Rinaldo Bellomo
doaj   +1 more source

Anticoagulation strategies for pediatric continuous renal replacement therapy

open access: yesJournal of Pediatric Critical Care
Continuous renal replacement therapy (CRRT) in children is quite challenging to manage because of their increased propensity for circuit clotting. The anticoagulant strategies are paramount in reducing the downtime in pediatric CRRT.
Aakash Chandran Chidambaram   +2 more
doaj   +1 more source

A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin‐1 to Restore Vascular Homeostasis After Ischemic Injury

open access: yesAdvanced Science, EarlyView.
TAX2‐NPs capture extracellular TSP‐1 in the injured liver and promote its macrophage‐mediated autophagic degradation. This process blocks TSP‐1/CD47 signaling, restores VEGFR2‐AKT activity, preserves endothelial function, and mitigates hepatic ischemia‐reperfusion injury.
Haorui Wang   +12 more
wiley   +1 more source

Comparison of catheter outcomes according to dialysis modality and clinical factors in patients with femoral dialysis catheters

open access: yesBMC Nephrology
Background Although femoral vein catheters are less preferred than internal jugular vein catheters, they are still actively used as an alternative. However, limited studies have assessed whether the patency of femoral vein catheters differs according to ...
A-Young Kim   +4 more
doaj   +1 more source

Renal Replacement Therapy in the Critically Ill Child

open access: yes, 2018
Objectives: Although renal replacement therapy is widely used in critically ill children, there have been few comprehensive population-based studies of its use.
Morris, KP   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy